Galen Partners
28
13M
16
0.82
10
0.39
11
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Stamford. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Galen Partners, startups are often financed by Sycamore Ventures, WI Harper Group, Harbinger Ventures. The meaningful sponsors for the fund in investment in the same round are Sycamore Ventures, Amkey Ventures, PTV Healthcare Capital. In the next rounds fund is usually obtained by Ziegler Meditech Equity Partners, PTV Healthcare Capital, Amkey Ventures.
The overall number of key employees were 5.
Comparing to the other companies, this Galen Partners performs on 2 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2012. Speaking about the real fund results, this VC is 26 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2020. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Medical Device, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Sharecare, InTouch Health, Aperio Technologies.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 10
- Exits
- 11
- Rounds per year
- 0.82
- Follow on index
- 0.39
- Investments by industry
- Health Care (21)
- Hospital (8)
- Manufacturing (7)
- Medical Device (7)
- Medical (6) Show 23 more
- Investments by region
-
- United States (27)
- Peak activity year
- 2012
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 206M
- Group Appearance index
- 0.86
- Avg. company exit year
- 16
- Avg. multiplicator
- 1.88
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cambrooke Therapeutics | 11 Apr 2016 | Food Products, Biotechnology, Other Healthcare, Fitness, Health Care, Pharmaceutical, Therapeutics, Nutrition | Late Stage Venture | 0 | United States, Massachusetts |
| lifeIMAGE | 18 Apr 2013 | Information Technology, Health Care, Hospital | Late Stage Venture | 15M | United States, Massachusetts, Newton |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.